Alzheimer's disease (AD) is a neurodegenerative disorder that leads to cognitive decline
and memory loss. Insulin resistance in central nervous system (CNS) is a common feature in …

Alzheimer disease (AD), the most common form of dementia, is a heterogenous disorder
with various pathobiological subtypes. In addition to the 4 major subtypes based on the …

A neuroinflammatory reaction in Alzheimer disease (AD) brains involves reactive astrocytes
that overexpress monoamine oxidase-B (MAO-B). 18F-(S)-(2-methylpyrid-5-yl)-6-[(3-fluoro-2 …

Astrocytes are key homeostatic and defensive cells of the central nervous system (CNS).
They undertake numerous functions during development and in adulthood to support and …

With reactive astrogliosis being established as one of the hallmarks of Alzheimer's disease
(AD), there is high interest in developing novel positron emission tomography (PET) tracers …

Alzheimer's disease is the most common cause of dementia. Cellular changes in the brains
of the patients suffering from Alzheimer's disease occur well in advance of the clinical …

In the 115 years since the discovery of Alzheimer's disease (AD), our knowledge, diagnosis,
and therapeutics have significantly improved. Biomarkers are the primary tools for clinical …

Post COVID-19 syndrome is determined as signs and symptoms that appear during or after
an infection consistent with SARS-CoV-2 disease, persist for more than 12 weeks and are …

Background: Measuring plasma glial fibrillary acidic protein (GFAP) alongside cortical
amyloid-β (Aβ) may shed light on astrocytic changes in aging and Alzheimer's disease (AD) …

Alzheimer's disease (AD) is a neurodegenerative disorder associated with neuron–glia
dysfunction and dysregulated miRNAs. We previously reported upregulated miR-124/miR …